Abstract: Antibodies that are capable of specifically binding and preventing the activation of TREM-1, a protein expressed on monocytes, macrophages and neutrophils with both good affinity and low viscosity at clinically relevant concentrations are described. Such antibodies find utility in the treatment of individuals with an inflammatory disease, such as rheumatoid arthritis and inflammatory bowel disease.
Description:Attached , Claims:Attached
| # | Name | Date |
|---|---|---|
| 1 | 202318031577-STATEMENT OF UNDERTAKING (FORM 3) [03-05-2023(online)].pdf | 2023-05-03 |
| 2 | 202318031577-Sequence Listing in txt [03-05-2023(online)].txt | 2023-05-03 |
| 3 | 202318031577-Sequence Listing in PDF [03-05-2023(online)].pdf | 2023-05-03 |
| 4 | 202318031577-REQUEST FOR EXAMINATION (FORM-18) [03-05-2023(online)].pdf | 2023-05-03 |
| 5 | 202318031577-PRIORITY DOCUMENTS [03-05-2023(online)].pdf | 2023-05-03 |
| 6 | 202318031577-POWER OF AUTHORITY [03-05-2023(online)].pdf | 2023-05-03 |
| 7 | 202318031577-FORM 18 [03-05-2023(online)].pdf | 2023-05-03 |
| 8 | 202318031577-FORM 1 [03-05-2023(online)].pdf | 2023-05-03 |
| 9 | 202318031577-DRAWINGS [03-05-2023(online)].pdf | 2023-05-03 |
| 10 | 202318031577-DECLARATION OF INVENTORSHIP (FORM 5) [03-05-2023(online)].pdf | 2023-05-03 |
| 11 | 202318031577-COMPLETE SPECIFICATION [03-05-2023(online)].pdf | 2023-05-03 |
| 12 | 202318031577-Proof of Right [27-10-2023(online)].pdf | 2023-10-27 |
| 13 | 202318031577-FORM 3 [27-10-2023(online)].pdf | 2023-10-27 |
| 14 | 202318031577-FORM 3 [18-04-2024(online)].pdf | 2024-04-18 |